Discovery by a proteomic approach of possible early biomarkers of drug-induced nephrotoxicity in medication-overuse headache

Table 1 Details of MOH patients and control subjects

	NSAIDs group	Triptans group	Mixtures group	Control group
No. of subjects	27	31	29	30
Age (years)	49.2 ± 7.8	46.0 ± 9.3	51.8 ± 9.9	48.1 ± 5.0
Gender (F/M)	23/4	28/3	27/2	26/4
MOH duration (years)	8.7 ± 6.0	7.9 ± 5.5	9.4 ± 6.6	N/A
Days with headache/month	25.3 ± 3.5	26.5 ± 4.6	24.4 ± 5.1	N/A
Daily drug intake	2.0 ± 1.3	1.4 ± 0.6	1.8 ± 0.8	N/A

ISSN: 1129-2377